CIPLA
Back to Balance Sheet
|
CIPLA Last 5 Year Net Current Assets History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Net Current Assets (Including Current Investments) | ₹17,765 Cr | ₹14,147 Cr | ₹11,772 Cr | ₹9,798 Cr | ₹8,590 Cr |
What is the latest Net Current Assets ratio of CIPLA ?
| Year | Net Current Assets |
|---|---|
| Mar2025 | ₹17,765 Cr |
| Mar2024 | ₹14,147 Cr |
| Mar2023 | ₹11,772 Cr |
| Mar2022 | ₹9,798 Cr |
| Mar2021 | ₹8,590 Cr |
How is Net Current Assets of CIPLA Trending?
| Years | Net Current Assets | % Change | |
|---|---|---|---|
| Mar2025 | ₹17,765 Cr | 25.58 | |
| Mar2024 | ₹14,147 Cr | 20.17 | |
| Mar2023 | ₹11,772 Cr | 20.15 | |
| Mar2022 | ₹9,798 Cr | 14.06 | |
| Mar2021 | ₹8,590 Cr | - | |
Compare Net Current Assets of peers of CIPLA
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| CIPLA | ₹124,098.3 Cr | 1.2% | -1.4% | -4.1% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹423,171.0 Cr | 3.5% | 6.2% | -4.2% | Stock Analytics | |
| DIVIS LABORATORIES | ₹173,172.0 Cr | -2.7% | -0.7% | 11% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹129,176.0 Cr | 0.6% | 9.1% | 19.7% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹103,869.0 Cr | 3.9% | 0.6% | -3.7% | Stock Analytics | |
| MANKIND PHARMA | ₹92,658.1 Cr | 1.4% | -6.9% | -15.2% | Stock Analytics | |
CIPLA Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| CIPLA | 1.2% |
-1.4% |
-4.1% |
| SENSEX | 1.6% |
2.7% |
6.3% |
You may also like the below Video Courses